Clinical determinants of survival and a predictive immune biomarker for immunotherapy in fibrolamellar carcinoma: A comprehensive institutional analysis. This is an ASCO Meeting Abstract from the 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results